HomeCompareACCD vs EQR

ACCD vs EQR: Dividend Comparison 2026

ACCD yields 28.49% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACCD wins by $80.8K in total portfolio value
10 years
ACCD
ACCD
● Live price
28.49%
Share price
$7.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$121.3K
Annual income
$15,341.97
Full ACCD calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — ACCD vs EQR

📍 ACCD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodACCDEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ACCD + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ACCD pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACCD
Annual income on $10K today (after 15% tax)
$2,421.65/yr
After 10yr DRIP, annual income (after tax)
$13,040.67/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, ACCD beats the other by $9,794.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACCD + EQR for your $10,000?

ACCD: 50%EQR: 50%
100% EQR50/50100% ACCD
Portfolio after 10yr
$80.9K
Annual income
$9,580.79/yr
Blended yield
11.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

ACCD
Analyst Ratings
7
Buy
13
Hold
Consensus: Hold
Price Target
$13.97
+99.0% upside vs current
Range: $5.00 — $52.00
Altman Z
-1.1
Piotroski
4/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACCD buys
0
EQR buys
0
No recent congressional trades found for ACCD or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricACCDEQR
Forward yield28.49%4.73%
Annual dividend / share$2.00$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$121.3K$40.5K
Annual income after 10y$15,341.97$3,819.61
Total dividends collected$81.1K$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldHold
Analyst price target$13.97$70.35

Year-by-year: ACCD vs EQR ($10,000, DRIP)

YearACCD PortfolioACCD Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$13,549$2,849.00$11,248$547.57+$2.3KACCD
2$18,105$3,607.58$12,701$666.53+$5.4KACCD
3$23,878$4,505.31$14,405$814.59+$9.5KACCD
4$31,102$5,553.08$16,413$999.84+$14.7KACCD
5$40,039$6,760.03$18,795$1,232.92+$21.2KACCD
6$50,975$8,133.20$21,639$1,527.95+$29.3KACCD
7$64,221$9,677.21$25,057$1,903.80+$39.2KACCD
8$80,110$11,394.16$29,197$2,385.87+$50.9KACCD
9$99,002$13,283.47$34,250$3,008.70+$64.8KACCD
10$121,274$15,341.97$40,467$3,819.61+$80.8KACCD

ACCD vs EQR: Complete Analysis 2026

ACCDStock

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.

Full ACCD Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this ACCD vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACCD vs SCHDACCD vs JEPIACCD vs OACCD vs KOACCD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.